Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Other Benefit Plans (Tables)

v3.21.2
Stock-Based Compensation and Other Benefit Plans (Tables)
6 Months Ended
Jun. 30, 2021
Stock-Based Compensation and Other Benefit Plans [Abstract]  
Summary of Stock-Based Compensation

Three Months Ended June 30,

Six Months Ended June 30,

2021

2020

2021

2020

(in thousands)

Stock-based compensation - equity awards

$

117

$

60

$

440

$

205

Stock-based compensation - liability awards

397

660

1,633

(2,054)

Total stock-based compensation

$

514

$

720

$

2,073

$

(1,849)

Stock Option Valuation Assumptions

Six Months Ended June 30,

2021

2020

Weighted average exercise price - ($/share)

$

3.14

$

1.23

Expected life in years

6.0

6.0

Average expected volatility

75

%

74

%

Risk-free interest rate

0.95

%

0.42

%

Weighted average grant date fair value - ($/share)

$

2.07

$

0.79

Stock Option Activity Stock option activity associated with the Monte Carlo model for the six months ended June 30, 2021 is provided below:

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

644

$

1.23

Granted

402

3.14

Exercised

Unvested shares forfeited

(687)

1.96

Vested shares expired

Outstanding at June 30, 2021

359

$

1.96

9.26

$

462

Exercisable at June 30, 2021

74

$

1.23

8.99

$

149

Stock option activity associated with the Black-Scholes model for the six months ended June 30, 2021 is provided below:

Number of Shares Underlying Options

Weighted Average Exercise Price Per Share

Weighted Average Remaining Contractual Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

1,804

$

1.38

Granted

Exercised

(980)

1.07

Unvested shares forfeited

(60)

2.33

Vested shares expired

Outstanding at June 30, 2021

764

$

1.70

1.73

$

1,181

Exercisable at June 30, 2021

663

$

1.61

1.59

$

1,087

Summary of Non Vested Awards

Restricted Stock

Weighted Average Grant Date Fair Value

(in thousands)

Non-vested shares outstanding at January 1, 2021

1,155

$

1.30

Awards granted

605

3.13

Awards vested

(543)

1.28

Awards forfeited

(462)

2.00

Non-vested shares outstanding at June 30, 2021

755

$

2.36

SAR Activity

Number of Shares Underlying SARs

Weighted Average Exercise Price Per Share

Term

Aggregate Intrinsic Value

(in thousands)

(in years)

(in thousands)

Outstanding at January 1, 2021

2,940

$

1.33

Granted

Exercised

(2,213)

1.18

Unvested SARs forfeited

(122)

2.33

Vested SARs expired

Outstanding at June 30, 2021

605

$

1.68

2.36

$

949

Exercisable at June 30, 2021

431

$

1.51

2.20

$

750